Cargando…
High SAA1 Expression Predicts Advanced Tumors in Renal Cancer
Renal cell carcinoma (RCC) is the most frequent malignant tumor of the kidney. 30% of patients with RCC are diagnosed at an advanced stage. Clear cell renal cell carcinoma (ccRCC) is the most common pathological subtype of RCC. Currently, advanced ccRCC lacks reliable diagnostic and prognostic marke...
Autores principales: | Li, Sen, Cheng, Yongbiao, Cheng, Gong, Xu, Tianbo, Ye, Yuzhong, Miu, Qi, Cao, Qi, Yang, Xiong, Ruan, Hailong, Zhang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168437/ https://www.ncbi.nlm.nih.gov/pubmed/34084746 http://dx.doi.org/10.3389/fonc.2021.649761 |
Ejemplares similares
-
LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation
por: Cheng, Gong, et al.
Publicado: (2020) -
Causes of Death Among Prostate Cancer Patients Aged 40 Years and Older in the United States
por: Ye, Yuzhong, et al.
Publicado: (2022) -
GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer
por: Cheng, Yongbiao, et al.
Publicado: (2019) -
Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer
por: Miao, Qi, et al.
Publicado: (2023) -
A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)